logo

For the Inventor, By the Inventor

Mountain View, CA, United States of America

Vivus, Inc.


USPTO Granted Patents = 45

% Expired Patents = 13.3


Trademarks = 20

Forward Citations = 1,457

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Virgil A Place (24 out of 50 patents)

silverMedal Leland F Wilson (16 out of 18 patents)

bronzeMedal Paul C Doherty, Jr (13 out of 16 patents)

4.  Thomas Najarian (12 out of 12 patents)

5.  Peter Y Tam (10 out of 10 patents)

6.  William L Smith (8 out of 8 patents)

7.  Neil Gesundheit (7 out of 14 patents)

8.  Mark S Hanamoto (6 out of 9 patents)

9.  Alfred P Spivack (5 out of 7 patents)

10.  Sean R Bennett (5 out of 8 patents)

11.  Randall G Berggren (4 out of 11 patents)

12.  Robert M Gale (4 out of 73 patents)

13.  Wesley Day (2 out of 2 patents)

14.  Barbara Troupin (2 out of 2 patents)

15.  Craig Peterson (2 out of 2 patents)


Core Competencies:
Type 2 Diabetes
Erectile Dysfunction
Weight Loss
Female Sexual Dysfunction
Obesity Treatment
Phosphodiesterase Inhibitors
Combination Therapy
Pulmonary Hypertension
Premature Ejaculation
Vasoactive Agents
Nitric Oxide
Dosage Forms

45 patents:

1. 10058532 - Methods of preventing progression to type 2 diabetes mellitus (2018-08-28),
2. 10028916 - Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and use (2018-07-24),
3. 9724327 - Methods of preventing progression to type 2 diabetes mellitus (2017-08-08),
4. 9011906 - Escalating dosing regimen for effecting weight loss and treating obesity (2015-04-21),
5. 9011905 - Low dose topiramate/phentermine composition and methods of use thereof (2015-04-21),
6. 8895058 - Low dose topiramate/phentermine composition and methods of use thereof (2014-11-25),
7. 8895057 - Escalating dosing regimen for effecting weight loss and treating obesity (2014-11-25),
8. 8802636 - Combination therapy for treatment of sleep apnea (2014-08-12),
9. 8580299 - Escalating dosing regimen for effecting weight loss and treating obesity (2013-11-12),
10. 8580298 - Low dose topiramate/phentermine composition and methods of use thereof (2013-11-12),
11. 8536138 - Treatment of pulmonary hypertension with carbonic anhydrase inhibitors (2013-09-17),
12. 8440671 - Compositions comprising a phoshodiesterase-5 inhibitor and their use in methods of treatment (2013-05-14),
13. 8071557 - Treatment of pulmonary hypertension with carbonic anhydrase inhibitors (2011-12-06),
14. 7674776 - Combination therapy for effecting weight loss and treating obesity (2010-03-09),
15. 7659256 - Combination therapy for effecting weight loss and treating obesity (2010-02-09),
Vivus, Inc., based in Mountain View, California, specializes in developing innovative therapies for various health conditions. The company focuses on areas such as type 2 diabetes prevention, weight loss therapy, and treatments for sleep apnea and pulmonary hypertension. Additionally, Vivus addresses sexual health issues, including female sexual dysfunction and erectile dysfunction, utilizing phosphodiesterase inhibitors in its therapeutic approaches. Through its commitment to advancing healthcare solutions, Vivus aims to improve patient outcomes across multiple domains.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Vivus, Inc.
45 Patents

#76 in Mountain View, CA

#1,829 in California

#7,773 in US

#15,419 in the World

Mountain View, CA (US)
Mountain View, CA, United States of America

Vivus, Inc.

Forward Citations = 1,457

25 inventors:

goldMedal Virgil A Place (24 out of 50 patents)

silverMedal Leland F Wilson (16 out of 18 patents)

bronzeMedal Paul C Doherty, Jr (13 out of 16 patents)

4.  Thomas Najarian (12 out of 12 patents)

5.  Peter Y Tam (10 out of 10 patents)

Please report any incorrect information to [email protected]
Loading…